These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 19843483

  • 1. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC.
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ, Lamp KC.
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [Abstract] [Full Text] [Related]

  • 3. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
    Levine DP, Lamp KC.
    Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
    [Abstract] [Full Text] [Related]

  • 5. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group.
    N Engl J Med; 2006 Aug 17; 355(7):653-65. PubMed ID: 16914701
    [Abstract] [Full Text] [Related]

  • 6. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 7. Daptomycin in the treatment of bacteremia.
    Sakoulas G, Golan Y, Lamp KC, Friedrich LV, Russo R.
    Am J Med; 2007 Oct 15; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
    [Abstract] [Full Text] [Related]

  • 8. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
    Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, Rybak MJ.
    Pharmacotherapy; 2007 Dec 15; 27(12):1611-8. PubMed ID: 18041881
    [Abstract] [Full Text] [Related]

  • 9. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
    Jobson S, Moise PA, Eskandarian R.
    Clin Ther; 2011 Oct 15; 33(10):1391-9. PubMed ID: 22015328
    [Abstract] [Full Text] [Related]

  • 10. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
    Gallagher JC, Perez ME, Marino EA, LoCastro LG, Abrardo LA, MacDougall C.
    Pharmacotherapy; 2009 Jul 15; 29(7):792-9. PubMed ID: 19558253
    [Abstract] [Full Text] [Related]

  • 11. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
    Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, Campion M, Abrutyn E, Levine DP, Price CS, Rehm SJ, Corey GR, Karchmer AW, S. aureus Endocarditis and Bacteraemia Study Group.
    J Antimicrob Chemother; 2008 Jan 15; 61(1):177-82. PubMed ID: 17999973
    [Abstract] [Full Text] [Related]

  • 12. Daptomycin experience in critical care patients: results from a registry.
    Brown JE, Fominaya C, Christensen KJ, McConnell SA, Lamp KC.
    Ann Pharmacother; 2012 Apr 15; 46(4):495-502. PubMed ID: 22454446
    [Abstract] [Full Text] [Related]

  • 13. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
    Owens RC, Lamp KC, Friedrich LV, Russo R.
    Am J Med; 2007 Oct 15; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
    [Abstract] [Full Text] [Related]

  • 14. Daptomycin for the treatment of surgical site infections.
    Chamberlain RS, Culshaw DL, Donovan BJ, Lamp KC.
    Surgery; 2009 Aug 15; 146(2):316-24. PubMed ID: 19628091
    [Abstract] [Full Text] [Related]

  • 15. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
    Shorr AF, Kunkel MJ, Kollef M.
    J Antimicrob Chemother; 2005 Nov 15; 56(5):923-9. PubMed ID: 16195255
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
    Sakoulas G.
    Clin Microbiol Infect; 2009 Dec 15; 15 Suppl 6():11-6. PubMed ID: 19917022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin.
    Katz DE, Martone WJ.
    Clin Ther; 2007 Nov 15; 29(11):2440-7. PubMed ID: 18158084
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.
    Forrest GN, Donovan BJ, Lamp KC, Friedrich LV.
    Ann Pharmacother; 2008 Feb 15; 42(2):213-7. PubMed ID: 18212253
    [Abstract] [Full Text] [Related]

  • 20. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 15; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.